Literature DB >> 16872639

A VEGF165-induced phenotypic switch from increased vessel density to increased vessel diameter and increased endothelial NOS activity.

Patricia Parsons-Wingerter1, Unni M Chandrasekharan, Terri L McKay, Krishnan Radhakrishnan, Paul E DiCorleto, Brian Albarran, Andrew G Farr.   

Abstract

Although vascular endothelial growth factor-165 (VEGF(165)) regulates numerous angiogenic cellular activities, its complex effects on vascular morphology are not highly quantified. By fractal-based, multiparametric branching analysis of 2D vascular pattern in the quail chorioallantoic membrane (CAM), we report that vessel density increased maximally at lower VEGF concentrations, but that vessel diameter and activity of endothelial nitric oxide synthase (eNOS) increased maximally at higher VEGF concentrations. Following exogenous application of human VEGF(165) to the CAM at embryonic day 7, vessel density and diameter were measured after 24 h at arterial end points by the fractal dimension (D(f)) and generational branching parameters for vessel area density (A(v)), vessel length density (L(v)) and vessel diameter (D(v)) using the computer code VESGEN. The VEGF-dependent phenotypic switch from normal vessels displaying increased vessel density to abnormal, dilated vessels typical of tumor vasculature and other pathologies resulted from an approximate threefold increase in VEGF concentration (1.25 to 5 microg/CAM) and correlated positively with increased eNOS activity. Relative to control specimens, eNOS activity increased maximally to 60% following VEGF treatment at 5 microg/CAM, compared to 10% at 1.25 microg/CAM, and was accompanied by no significant change in activity of inducible NOS. In summary, VEGF(165) induced a phenotypic switch from increased vessel density associated with low VEGF concentration, to increased vessel diameter and increased eNOS activity at high VEGF concentration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16872639     DOI: 10.1016/j.mvr.2006.05.008

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  14 in total

Review 1.  Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Matrix Biol       Date:  2015-04-22       Impact factor: 11.583

2.  For Application to Human Spaceflight and ISS Experiments: VESGEN Mapping of Microvascular Network Remodeling during Intestinal Inflammation.

Authors:  Patricia Parsons-Wingerter; Hans-Christian Reinecker
Journal:  Gravit Space Biol Bull       Date:  2012-10-01

3.  eNOS overexpression exacerbates vascular closure in the obliterative phase of OIR and increases angiogenic drive in the subsequent proliferative stage.

Authors:  Kevin Edgar; Thomas A Gardiner; Rien van Haperen; Rini de Crom; Denise M McDonald
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-03       Impact factor: 4.799

4.  Ultrasound Evaluation of Anti-Vascular Endothelial Growth Factor-Induced Changes in Vascular Response Following Tendon Injury.

Authors:  Corinne N Riggin; Susan M Schultz; Chandra M Sehgal; Louis J Soslowsky
Journal:  Ultrasound Med Biol       Date:  2019-04-30       Impact factor: 2.998

5.  Role of VEGF and tissue hypoxia in patterning of neural and vascular cells recruited to the embryonic heart.

Authors:  Hongbin Liu; Qiwei Yang; Krishnan Radhakrishnan; Dedra E Whitfield; Camille L M Everhart; Patricia Parsons-Wingerter; Steven A Fisher
Journal:  Dev Dyn       Date:  2009-11       Impact factor: 3.780

6.  Oscillation of angiogenesis with vascular dropout in diabetic retinopathy by VESsel GENeration analysis (VESGEN).

Authors:  Patricia Parsons-Wingerter; Krishnan Radhakrishnan; Mary B Vickerman; Peter K Kaiser
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-24       Impact factor: 4.799

7.  VESGEN 2D: automated, user-interactive software for quantification and mapping of angiogenic and lymphangiogenic trees and networks.

Authors:  Mary B Vickerman; Patricia A Keith; Terri L McKay; Dan J Gedeon; Michiko Watanabe; Monica Montano; Ganga Karunamuni; Peter K Kaiser; Jonathan E Sears; Quteba Ebrahem; Daniela Ribita; Alan G Hylton; Patricia Parsons-Wingerter
Journal:  Anat Rec (Hoboken)       Date:  2009-03       Impact factor: 2.064

8.  The mouse retina in 3D: quantification of vascular growth and remodeling.

Authors:  Florian Milde; Stephanie Lauw; Petros Koumoutsakos; M Luisa Iruela-Arispe
Journal:  Integr Biol (Camb)       Date:  2013-12       Impact factor: 2.192

9.  A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo.

Authors:  Yi Xu; Hui Zhao; Ying Zheng; Qing Gu; Jianxing Ma; Xun Xu
Journal:  Mol Vis       Date:  2010-10-07       Impact factor: 2.367

10.  Tumor Vascular Morphology Undergoes Dramatic Changes during Outgrowth of B16 Melanoma While Proangiogenic Gene Expression Remains Unchanged.

Authors:  Elise Langenkamp; Franziska M Vom Hagen; Peter J Zwiers; Henk E Moorlag; Jan P Schouten; Hans-Peter Hammes; Annette S H Gouw; Grietje Molema
Journal:  ISRN Oncol       Date:  2011-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.